What Researchers Did
This study investigated the effects of hyperbaric oxygen therapy (HBOT) on gingival wound healing in 16 head and neck radiation patients, comparing cellular markers to those in 6 healthy subjects.
What They Found
Researchers observed that after HBOT, levels of apoptosis, mitochondrial dynamics, cell proliferation, and inflammation in irradiated gingiva were restored to a similar level as in healthy gingiva. Specifically, key markers such as transforming growth factor beta (TGF-β), phospho-nuclear factor kappa-light-chain-enhancer of activated B cells (p-NFκB), nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), phospho-dynamin-related protein 1 at ser616 (p-Drp1), and dynamin-related protein 1 (Drp1) showed no significant differences between irradiated gingiva post-HBOT and healthy gingiva.
What This Means for Canadian Patients
For Canadian patients undergoing head and neck radiation, hyperbaric oxygen therapy could offer a way to improve wound healing in the gingiva, potentially reducing complications. This therapy may help restore cellular processes in damaged tissues, leading to better oral health outcomes after radiation treatment.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A limitation of this study is its relatively small sample size of 16 patients and 6 healthy subjects.